Mohsen Aarabi

Mohsen Aarabi

Auto-generated profile, based on publicly available information

Mohsen Aarabi

Department of Community Medicine, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2011 in Expert Review of Clinical Pharmacology
Verified
Journal Article
Closed access
KYKaren Rowland Yeo
Karen Rowland Yeo
MAMohsen Aarabi
Mohsen Aarabi
MJMasoud Jamei
Masoud Jamei
ARAmin Rostami-Hodjegan
Amin Rostami-Hodjegan
Current guidance issued by the US FDA to assess the impact of renal impairment on the pharmacokinetics of a drug under development has recently been updated to include evaluation of drugs with nonrenal elimination routes. Renal impairment not only affects elimination of the drug in the kidney, but also the nonrenal route of drugs that are extensively metabolized in the liver. Renal failure may influence hepatic drug metabolism either by inducing or suppressing hepatic enzymes, or by its effects on other variables such as protein binding, hepatic blood flow and accumulation of metabolites. Prior simulation of the potential exposure of individuals with renal impairment may help in the selection of a safe and effective dosage regimen. In this article, we discuss the application of a systems biology approach to simulate drug disposition in subjects with renal impairment.

1 December 2011 in Clinical Pharmacokinetics
Verified
Journal Article
Closed access
PDF file
CGCyrus Ghobadi
Cyrus Ghobadi
TJTrevor N. Johnson
Trevor N. Johnson
MAMohsen Aarabi
Mohsen Aarabi
LALisa M. Almond
Lisa M. Almond
AAAurel Constant Allabi
Aurel Constant Allabi
ARAmin Rostami-Hodjegan
Amin Rostami-Hodjegan

11 August 2010 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
PDF file
MAMahmoud Aarabi
Mahmoud Aarabi
TMToktam Memariani
Toktam Memariani
SASoheila Arefi
Soheila Arefi
MAMohsen Aarabi
Mohsen Aarabi
SZSedigheh Hantoosh Zadeh
Sedigheh Hantoosh Zadeh
MMMohammad Hossein Modarressi
Mohammad Hossein Modarressi
We investigated polymorphisms of plasminogen activator inhibitor-1 (PAI-1), angiotensin converting enzyme (ACE ) and coagulation factor XIII (FXIII) genes and their association with recurrent spontaneous abortion (RSA) in Iranian patients and normal healthy controls. Ten (18.5%) patients were homozygote (4G/4G) for PAI-1 polymorphism, in contrast with two (2%) controls (p = 0.001). Patients with homozygote 4G mutation were significantly more prone to RSA in contrast to others (odds ratio: 11.0, 95% CI: 2.3–52.4). Nineteen (30.2%) patients and 25 (26.6%) controls were homozygote (DD) for ACE polymorphism. We observed only two patients and one control with homozygosity (34leu) for FXIII polymorphism. 4G/4G polymorphism for PAI-1 gene could be a thrombophilic mutation leading to abortion in Iranian population.

15 November 2011 in Pakistan Journal of Biological Sciences
Verified
Journal Article
Closed access
ABAfshin Gholipour Baradari
Afshin Gholipour Baradari
AZAmir Emami Zeydi
Amir Emami Zeydi
MAMohsen Aarabi
Mohsen Aarabi
RGRahman Ghafari
Rahman Ghafari
Perioperative hyperglycemia is common in patients with type 2 diabetes undergoing Coronaiy Arteiy Bypass Graft (CABG) surgery and there is a direct relation between postoperative hyperglycemia and mortality rate in these patients. The aim of the present study is to determine the efficacy of metformin on glycemic control in diabetic patients after CABG surgery. In a randomized double blind clinical trial, 100 patients with type 2 diabetes admitted in open heart ICU after CABG surgeiy in Mazandaran Heart Center were enrolled. They were randomly assigned to two intervention and control groups. Three hours after extubation, therapeutic antiglycemic regimens were applied in these two groups and continued for three days. Intervention group received regular insulin infusion along with two metformin 500 mg tablets per twelve hours while control group received regular insulin infusion with two placebo tablets per twelve hours. Blood glucose level and other parameters were measured andrecorded in determined intervals. To analyze the data, independent T-test, paired T-test, Mann-Whitney and repeated measure ANOVA tests were employed. Mean blood glucose level was not significantly different in the two groups at the beginning of the ICU admission; however, mean glucose level in insulin-metformin group, twelve hours after the initiation of the study, was significantly lower than insulin group (p<0.05). In addition, mean doses of potassium and insulin demand as well as mean number of episodes of hyperglycemia, hypoglycemia and glucose levels out of the accepted range were significantly lower in insulin-metformin group (p<0.05). Alterations in mean levels of lactate, BE, pH and creatinine were not statistically significant in these two groups. It seems that adding metformin to insulin leads to a better glycemic control in type two diabetic patients undergoing CABG surgeiy without causing metabolic acidosis. Therefore, it might be a potential option in blood glucose control protocol in this group of patients. © 2011 asian network for scientific information

15 May 2012 in Perfusion
Verified
Journal Article
Closed access
RGR Ghafari
R Ghafari
ABA Gholipour Baradari
A Gholipour Baradari
AFA Firouzian
A Firouzian
MNM Nouraei
M Nouraei
MAM Aarabi
M Aarabi
AZA Emami Zeydi
A Emami Zeydi
Introduction: Cognitive dysfunction increasingly has been recognized as a complication after cardiac surgery. Different methods have been considered for the reduction of cognitive dysfunction after cardiac surgery. One of these methods is by using lidocaine during surgery. The aim of this study was to determine the effects of adding lidocaine to the cardioplegia solution on cognitive impairment after coronary artery surgery. Design and methods: In a prospective, randomized, double-blind trial, 110 patients aged between 20-70 years, scheduled for elective CABG surgery using cardiopulmonary bypass, were recruited into the study. They were randomized into two groups who received either cardioplegia solution containing lidocaine 2 mg/kg or procaine hydrochloride 5 mg/kg. The neurocognitive test used in this study was the Mini Mental State Examination (MMSE) or Folstein test. The test was done on the day before and 10 days and 2 months after the operation. Results: In the procaine group, the total score after 10 days decreased significantly compared to the preoperative score (mean difference 0.68; 95% CI: 0.20 to 1.17, p=0.006). Comparison between mean differences after 10 and 60 days of operation between the lidocaine and procaine groups were statistically significant, p-value 0.017 and 0.013, respectively. There was no cognitive impairment in the lidocaine group, but, in the procaine group, four patients (7.7%) after 10 days and one patient (1.9%) after both 10 and 60 days had cognitive impairment, p=0.051. Conclusions: Administration of lidocaine compared to that of procaine through the cardioplegia solution had a better effect on cognitive function after coronary artery bypass graft surgery.

8 September 2022 in Jundishapur Journal of Natural Pharmaceutical Products
Verified
Journal Article
Open access
PDF file
DPDelaram Poorkazemi
Delaram Poorkazemi
ASAli Malekzadeh Shafaroudi
Ali Malekzadeh Shafaroudi
PNPegah Nasiri
Pegah Nasiri
MAMohsen Aarabi
Mohsen Aarabi
JSJavad Mehrani Sabet
Javad Mehrani Sabet
Context: Mouth rinses have been recognized as the main adjuvant or primary treatment to address many issues relating to dentistry. Previous studies have investigated the anti-inflammatory, anti-arthritic, anti-viral, antioxidant, anti-fungal, and anti-bacterial effects of Aloe vera. Recently, Aloe vera has been applied to treat several dental and oral conditions. Methods: Official web pages, such as Scopus, PubMed, and Microsoft were searched for collecting the required data using the keywords Aloe vera, Aloe vera mouthwash, Aloe vera mouth rinse, and dentistry. After checking the abstracts and titles, all relevant papers were retrieved for performing a full-text review. Results: Aloe vera was effective in reducing periodontal indices compared to chlorhexidine. It was also effective in treating oral diseases such as mucositis, postoperative pain, trismus, and dry socket incidence after the third molar extraction. Aloe vera decreased the number of colony-forming units during scaling and root planning (SRP). Conclusions: Aloe vera mouthwash was just as effective as other commercial mouthwashes in reducing the severity of radiation-induced mucositis, periodontal disease, the amount of S. mutans, the number of colony-forming units during SRP, and other situations which required a mouth rinse for the acceleration of treatment.